Total Reports
228
Above-median volume
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for American Curl Shorthair (Cat) in the FDA Center for Veterinary Medicine openFDA extract. Browse cat breeds, reactions, and outcomes below.
By recorded gender -- every report on file for American Curl Shorthair, no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, American Curl Shorthair ranks #178 of 510 by total reports (228) and #205 of 275 by death-coded share (3.5%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. American Curl Shorthair has 228 reports now versus 220 in that prior snapshot: 8 more (3.6%).
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to American Curl Shorthair changesTotal Reports
228
Above-median volume
Deaths Reported
8
of 228 reports
Death-coded share of reports
3.5%
Below-median death-coded share
Avg Age at Report
7.3 yr
5.1 kg avg weight
A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.
Share of reports coded as a fatality
Share of reports resulting in euthanasia
Share of reports coded "Recovered/Normal"
Change in annual report volume over the last 5 complete years
3.5% of 228 american curl shorthair reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2012 | 1 | |
| 2015 | 2 | |
| 2016 | 11 | |
| 2017 | 3 | |
| 2018 | 4 | |
| 2019 | 16 | |
| 2020 | 8 | |
| 2021 | 12 | |
| 2022 | 26 | |
| 2023 | 30 | |
| 2024 | 57 | |
| 2025 | 54 | |
| 2026 | 4 | |
Signature read: American Curl Shorthair's 3.5% death-coded share is in the lower third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, American Curl Shorthair sits at #178 of 510 by report volume among all breeds and #18 of 55 among cat breeds, with 228 reports and 8 (3.5%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #205 of 275. Mean age at report: 7.3 years, average weight 5.1 kg (11.2 lbs).
Top reported signs: Application site hair loss (58), Vomiting (29), Lethargy (see also Central nervous system depression in Neurological) (18). Most-referenced drug: Selamectin;Sarolaner (106 reports), followed by Frunevetmab (48) and Cefovecin (29).
Outcome coding on 228 status-recorded reports is dominated by Outcome Unknown (40.4%). Annual submissions ranged 1-2,026 across 13 years on file.
Showing 6 of 54 cat breeds in our dataset, ranked by closest report volume.
Two openFDA-derived peer sets for American Curl Shorthair, both outside the Cat family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds with ≥50 reports (3.5% death-coded here).
Nearest other-species breeds by reported average weight (5.1 kg here).
What to do with this cat
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →